Crimean-Congo Hemorrhagic Fever (CCHF)
Why in News?
Scientists have recently identified multiple antibody targets that could lead to the development of the first effective treatments for the Crimean-Congo Hemorrhagic Fever.
About CCHF
- Definition: A severe, potentially fatal zoonotic viral disease that triggers intense hemorrhagic (bleeding) outbreaks in humans.
- Pathogen: Caused by the Nairovirus (or Orthonairovirus), which belongs to the Bunyaviridae family.
- Fatality Rate: Extremely lethal, maintaining a high mortality rate ranging between 10% and 40%.
- History: First discovered in the Crimea in 1944 and later identified in the Congo in 1956. Researchers realized in 1969 that both outbreaks were caused by the exact same virus.
Geographic Distribution
- Endemic Zones: Frequently spreads across Africa, the Balkans, the Middle East, and Asia.
- Tick Alignment: Its global presence directly mirrors the geographic range of the Hyalomma tick.
- Unreported Cases: Public health experts state the true global risk remains poorly defined due to underreporting and misdiagnoses.
Transmission (How it Spreads?)
- Tick Bites: Primarily transmitted to humans through the bite of infected Hyalomma ticks.
- Animal Contact: Spread via direct contact with the blood, fluids, or tissues of infected livestock (like cattle, sheep, and goats) during or right after slaughter.
- Human-to-Human: Spreads between people through close contact with infected blood, bodily secretions, or organs.
- Hospital Outbreaks: Can spread rapidly in healthcare settings due to poorly sterilized medical equipment or reused needles.
- High-Risk Groups: Slaughterhouse staff, livestock farmers, veterinarians, and healthcare workers face the highest risk.
Symptoms and Stages
- Incubation: Lasts 1 to 9 days after a tick bite, or up to 13 days following contact with infected blood.
- Sudden Onset: Begins abruptly with high fever, severe headache, muscle aches, neck pain, dizziness, and sensitivity to light.
- Gastrointestinal Distress: Early stages often involve vomiting, nausea, abdominal pain, and non-bloody diarrhea.
- Hemorrhagic Phase: Rapidly progresses into severe internal and external bleeding, resulting in nosebleeds, large bruises, and uncontrolled bleeding at injection sites.
- Organ Failure: Can result in fatal complications, including sudden liver failure, kidney failure, and acute nervous system changes like confusion or drowsiness.
Treatment and Prevention
- No Approved Vaccine: There is currently no safe or effective vaccine available for either humans or animals.
- Supportive Care: Treatment primarily focuses on symptom management, intensive hydration, and blood product transfusions to manage clotting issues.
- Antiviral Use: The antiviral drug Ribavirin is frequently used and has shown potential clinical benefits in treating infections.
- Animal Management: Livestock can be kept in tick-free quarantine zones for 14 days before slaughter to eliminate the risk of transmission.
- Personal Protection: Individuals in endemic areas are advised to wear protective clothing, use insect repellents, and strictly avoid direct contact with animal fluids.
